CEBIOTEX

Barcelona, Catalonia

OncologyCAR-TPhase II

What changed

NIH R01 · $0.6M · Immunometabolic Programs Controlled by ER Stress in Cancer

Jun 2025Grant renewalJun 18, 2025Source filing (opens the source filing in a new tab)

Momentum

53no change

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
R01 · $829k · non-dilutive
Jun 11, 2025
WEILL MEDICAL COLL OF CORNELL UNIV · PI MORALES, DIANA K. · NIAID · award ends May 31, 2030 · Molecular Programs Governing Enterococcal Translocation
NIH RePORTER · NIH RePORTER 11131972 (opens the source filing in a new tab)
Trial
PHASE2 registered
Aug 20, 2024
Pancreatic Carcinoma · RECRUITING · sponsor: CEBIOTEX · CEB-01 in Locally Resectable Pancreatic Cancer
ClinicalTrials.gov · NCT06538857 (opens the source filing in a new tab)
Grant
R01 · $580k · non-dilutive
Jul 1, 2023
WEILL MEDICAL COLL OF CORNELL UNIV · PI CUBILLOS-RUIZ, JUAN R · NCI · award ends Jun 30, 2028 · Immunometabolic Programs Controlled by ER Stress in Cancer
NIH RePORTER · NIH RePORTER 11128680 (opens the source filing in a new tab)
Grant
U54 · $2.1M · non-dilutive
Aug 25, 1997
PONCE SCHOOL OF MEDICINE · PI TORRES-RUIZ, JOSE A · NIMHD · award ends May 31, 2027 · Administrative Core
NIH RePORTER · NIH RePORTER 11161312 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
new_entity links the trial record at 0.26{"reasons":["same therapeutic area"]}

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

NIH R01 · $0.6M · Immunometabolic Programs Controlled by ER Stress in Cancer
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH U54 · $2.1M · Administrative Core
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.8M · Molecular Programs Governing Enterococcal Translocation
Jun 2025New grantSource (opens the source filing in a new tab)
Phase II trial registered: CEB-01 in Locally Resectable Pancreatic Cancer
May 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: CEB-01 in Locally Resectable Pancreatic Cancer
May 2025Trial recruitingSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

R01 · $829k · non-dilutive

PHASE2 registered

R01 · $580k · non-dilutive

U54 · $2.1M · non-dilutive